The United Nations agency in its medical products alert said the...
Category:
Health
Latest
Star Health ties-up with Standard Chartered Bank
Star Health and Allied Insurance has collaborated with Standard...
India’s PB Fintech posts smaller Q1 loss on loan, insurance demand
Yashish Dahiya, co-founder of Policybazaar The company's revenue...
India reports 22,854 new coronavirus cases, 126 deaths in last 24 hrs
Maharashtra, Kerala, Punjab, Karnataka, Gujarat and Tamil Nadu continue to report a high number of fresh COVID-19 cases and together account for 85.91 per cent of the new cases of the coronavirus infection reported in the country in a span of 24 hours, the Union health ministry said on Thursday.Meanwhile, the nationwide COVID-19 vaccination has reported 2,52,89,693 crore coverage, as per the information shared by the union health ministry yesterday.
India’s drug regulator panel eases use condition for home-grown vaccine
BENGALURU: An expert panel of India’s drug regulator has recommended relaxing norms for the use of a government-backed coronavirus vaccine after it was found to be highly effective in a late-stage trial, the regulator said on its website on Thursday....
Under Ayushman Bharat, 3 crore women screened for Cancer
“In the past two years, under the Ayushman Bharat Yojana alone, three crore women from poor and rural families got themselves screened for cervical and breast cancer. It means the woman who would have never spoken about the diseases now have support from the government and she utilised the policy and under that she got herself screened, which means she is prepared for a medical challenge and she has prepared herself for solutions,” the union minister said.
Only private doctors on Covid-19 duty covered by government insurance: Bombay High Court
The scheme clearly states that for a private healthcare provider to be covered under the scheme, he or she must be drafted or requisitioned by the state/Centre for Covid-19-related responsibilities, the order stated.
Govt approves creation of PM Swasthya Suraksha Nidhi as single non-lapsable reserve fund for health
Pradhan Mantri Swasthya Suraksha Nidhi (PMSSN) is a non-lapsable reserve fund for health in the public account and proceeds of share of health in the health and education cess will be credited into PMSSN, the statement said.
The accruals into the PMSSN will be utilised for the flagship schemes of the health ministry such as Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), Ayushman Bharat – Health and Wellness Centres (AB-HWCs), National Health Mission, Pradhan Mantri Swasthya Suraksha Yojana (PMSSY), Emergency and disaster preparedness and responses during health emergencies and any future programme/scheme that targets to achieve progress towards SDGs and the targets set out in the National Health Policy (NHP) 2017.
Not right time for ‘vaccine passports’: WHO
Addressing a press conference this week, WHO emergencies chief Michael Ryan said that “at the present time the use of certification of vaccination as a requirement for travel is not advised because quite simply vaccination is just not available enough around the world and is not available certainly on an equitable basis.”
India reports 17,921 new coronavirus cases, 133 deaths in last 24 hrs
With 96,548 active coronavirus infections, Maharashtra has the highest number of active cases. Kerala follows with 37,446 active COVID-19 cases. As many as 2,43,67,906 vaccine doses have been administered so far.
Delhi government to open special women mohalla clinics
“In the first phase, 100 ‘Mahila Mohalla Clinics’ are proposed to be established in different parts of Delhi, which will be progressively increased to at least one clinic in each ward. I understand that this is taken in the direction of keeping half of its population respectfully healthy, which will be the most important step so far in the history of 75 years of independent India. For a step such as this, what better time can there be, than the 75th anniversary of our independence,” Deputy Chief Minister Manish Sisodia, said.
Intranasal Covid vaccine candidate in early clinical stage of development in India: Govt
“The interval period between the two doses is presently 21 days. The schedule will be finalized after the phase I clinical trial data. Currently, in phase I clinical trial, single dose and two dose schedules are being tested,” the minister said.
Pfizer wants to make vaccine in India if faster clearance, export freedom assured -sources
Pfizer and Moderna, whose shots are more expensive than the AstraZeneca one being used in India’s immunisation campaign, are not comfortable with strict price and export restrictions, one of the sources said.